相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel p21 attenuator which is structurally related to sorafenib
Hiromi I. Wettersten et al.
CANCER BIOLOGY & THERAPY (2013)
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Jian Hu et al.
CELL (2012)
DNA Damage Signals through Differentially Modified E2F1 Molecules To Induce Apoptosis
Jasmyne Carnevale et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides
Christopher J. Chene et al.
BIOMATERIALS (2011)
Essential roles for Pot1b in HSC self-renewal and survival
Yang Wang et al.
BLOOD (2011)
Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy
Hiromi Inoue et al.
CANCER BIOLOGY & THERAPY (2011)
SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing
Yupeng Chen et al.
GENES & DEVELOPMENT (2011)
p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation
M. Xia et al.
ONCOGENE (2011)
Role of telomeres and telomerase in cancer
Jerry W. Shay et al.
SEMINARS IN CANCER BIOLOGY (2011)
Alternative lengthening of telomeres: models, mechanisms and implications
Anthony J. Cesare et al.
NATURE REVIEWS GENETICS (2010)
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Jeremy D. Henson et al.
NATURE BIOTECHNOLOGY (2009)
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
Kim A. Woodrow et al.
NATURE MATERIALS (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres
Nadya Dimitrova et al.
GENES & DEVELOPMENT (2006)
A novel apoptosis pathway activated by the carboxyl terminus of p21
C Dong et al.
BLOOD (2005)
Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis
T Hershko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
MDC1 is required for the intra-S-phase DNA damage checkpoint
M Goldberg et al.
NATURE (2003)
MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways
ZK Lou et al.
NATURE (2003)
MDC1 is a mediator of the mammalian DNA damage checkpoint
GS Stewart et al.
NATURE (2003)
Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio
D Javelaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
BAX and BAK mediate p53-independent suppression of tumorigenesis
K Degenhardt et al.
CANCER CELL (2002)
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
C Scheel et al.
ONCOGENE (2001)
PUMA, a novel proapoptotic gene, is induced by p53
K Nakano et al.
MOLECULAR CELL (2001)
Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres
XD Zhu et al.
NATURE GENETICS (2000)
分享论文
